You have 9 free searches left this month | to do more

gt0918

Gt0918 is a drug used to treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) and Covid19. Gt0918 is being actively studied in 2 studies and prior, has been studied in 1.

Top SponsorsTop SitesTop Investigators
Suzhou Kintor Pharmaceutical Inc,Chesapeake Urology Research Associates
Comprehensive Cancer Centers of Nevada
G U Research Network
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
S
Completed
  • Metastatic Castrate Resistant Prostate Cancer (mCRPC)
  • GT0918
  • Towson, Maryland
  • +5 more
2020-03-13
Mar 13, 2020
S
Recruiting
  • Covid19
  • GT0918
  • +2 more
  • Hialeah, Florida
  • +2 more
2021-11-23
Nov 23, 2021
S
Recruiting
  • Metastatic Castrate Resistant Prostate Cancer (mCRPC)
  • GT0918
  • Athens, Georgia
  • +9 more
2021-07-21
Jul 21, 2021